12 employees
OriCiro Genomics develops and commercializes cell-free synthesis and amplification technologies of large DNA molecules.
2018
$1.8M
from 1 investors over 1 rounds
OriCiro Genomics, Inc. raised $1.8M on July 20, 2021
Investors: Japan Finance Corporation